- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/30 - Oxygen or sulfur atoms
Patent holdings for IPC class C07D 233/30
Total number of patents in this class: 15
10-year publication summary
|
0
|
2
|
0
|
3
|
1
|
0
|
1
|
2
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Corporation | 1409 |
5 |
| Bristol-myers Squibb Company | 4757 |
1 |
| LG Chem, Ltd. | 17970 |
1 |
| Janssen Pharmaceutica N.V. | 3147 |
1 |
| DSM IP Assets B.V. | 5387 |
1 |
| University of South Florida | 1907 |
1 |
| Ardea Biosciences, Inc. | 68 |
1 |
| Fudan University | 770 |
1 |
| Novabay Pharmaceuticals, Inc. | 26 |
1 |
| TES Pharma S.r.l. | 20 |
1 |
| BASF SE | 105 |
1 |
| Other owners | 0 |